FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2074838036> ?p ?o ?g. }

• W2074838036 endingPage "32" @default.
• W2074838036 startingPage "26" @default.
• W2074838036 abstract "The results of four challenge studies following co-administration of cats with a trivalent vaccine (feline calicivirus, feline herpes virus and feline panleukopenia virus; Versifel CVR) and feline leukaemia virus vaccine (Versifel FeLV) are described. Nine week old cats received two vaccinations, 21 days apart, administered concurrently (two vaccinations) or simultaneously (single vaccination) while non-vaccinated control cats received sterile water. Three weeks after the second dose all cats were challenged; clinical observations, rectal or tympanic temperatures and blood samples were collected throughout the study. In all studies tympanic temperatures remained normal throughout the study. In the FeLV study mild, transient local reactions were seen in vaccinated cats. Following challenge, persistent antigenaemia was detected in 10/11 (91%) of non-vaccinated cats compared to 4/16 (25%) concurrent and 3/15 (20%) simultaneous vaccinated cats. Following challenge with FHV, cats in all groups showed abnormal clinical signs; however, there were significant differences in clinical scores between both the vaccinated groups and the non-vaccinated group. Antibody responses to FHV in vaccinated and non-vaccinated cats showed a rapid increase following challenge. Following challenge with FPV no abnormal clinical observations were seen in any of the treatment groups. All (6/6) non-vaccinated cats demonstrated a greater than 50% reduction in white blood cells counts, and also showed a reduction in lymphocyte and neutrophil counts. Two of 6 concurrently vaccinated cats also had a greater than 50% reduction in neutrophil counts and another cat (1/6) had similar reductions in monocytes. The antibody responses to FPV following vaccination increased rapidly, peaking prior to second vaccination and remaining stable thereafter; non-vaccinated cats sero-converted following challenge. Following challenge with FCV, non-vaccinated cats had a high incidence of ulcers, with two to three vaccinated cats also observed with this clinical sign. However, there were highly significant (P < 0.0001) differences between both vaccinated treatment and the non-vaccinated groups in clinical scores. The antibody responses to FCV in vaccinated and non-vaccinated cats showed a rapid increase following challenge. In conclusion, the results from this study demonstrate that concurrent or simultaneous administration of these two vaccines resulted in equivalent efficacy; both vaccine administration regimes showing significant differences in clinical scores or lower levels of persistent antigenaemia when compared to non-vaccinated control cats following challenge." @default.
• W2074838036 created "2016-06-24" @default.
• W2074838036 creator A5013482923 @default.
• W2074838036 creator A5024757397 @default.
• W2074838036 creator A5041770160 @default.
• W2074838036 creator A5048603758 @default.
• W2074838036 creator A5066369146 @default.
• W2074838036 creator A5073827597 @default.
• W2074838036 creator A5080287432 @default.
• W2074838036 creator A5084438850 @default.
• W2074838036 date "2014-01-01" @default.
• W2074838036 modified "2023-09-27" @default.
• W2074838036 title "Co-administration of an adjuvanted FeLV vaccine together with a multivalent feline vaccine to cats is protective against virulent challenge with feline leukaemia virus, calicivirus, herpes virus and panleukopenia virus" @default.
• W2074838036 cites W1854682421 @default.
• W2074838036 cites W2008204694 @default.
• W2074838036 cites W2016290515 @default.
• W2074838036 cites W2042037118 @default.
• W2074838036 cites W2048559211 @default.
• W2074838036 cites W2053221848 @default.
• W2074838036 cites W2059844991 @default.
• W2074838036 cites W2067648614 @default.
• W2074838036 cites W2076258503 @default.
• W2074838036 cites W2081208187 @default.
• W2074838036 cites W2086005686 @default.
• W2074838036 cites W2086332504 @default.
• W2074838036 cites W2100799797 @default.
• W2074838036 cites W2118688691 @default.
• W2074838036 cites W2135906189 @default.
• W2074838036 cites W2149059527 @default.
• W2074838036 cites W2155470986 @default.
• W2074838036 cites W2159746690 @default.
• W2074838036 cites W2162834550 @default.
• W2074838036 cites W2166494739 @default.
• W2074838036 cites W4210974950 @default.
• W2074838036 cites W4211254679 @default.
• W2074838036 cites W4240266822 @default.
• W2074838036 cites W4254552650 @default.
• W2074838036 doi "https://doi.org/10.1016/j.trivac.2013.12.002" @default.
• W2074838036 hasPublicationYear "2014" @default.
• W2074838036 type Work @default.
• W2074838036 sameAs 2074838036 @default.
• W2074838036 citedByCount "2" @default.
• W2074838036 countsByYear W20748380362015 @default.
• W2074838036 countsByYear W20748380362021 @default.
• W2074838036 crossrefType "journal-article" @default.
• W2074838036 hasAuthorship W2074838036A5013482923 @default.
• W2074838036 hasAuthorship W2074838036A5024757397 @default.
• W2074838036 hasAuthorship W2074838036A5041770160 @default.
• W2074838036 hasAuthorship W2074838036A5048603758 @default.
• W2074838036 hasAuthorship W2074838036A5066369146 @default.
• W2074838036 hasAuthorship W2074838036A5073827597 @default.
• W2074838036 hasAuthorship W2074838036A5080287432 @default.
• W2074838036 hasAuthorship W2074838036A5084438850 @default.
• W2074838036 hasBestOaLocation W20748380361 @default.
• W2074838036 hasConcept C126322002 @default.
• W2074838036 hasConcept C12914427 @default.
• W2074838036 hasConcept C159047783 @default.
• W2074838036 hasConcept C203014093 @default.
• W2074838036 hasConcept C22070199 @default.
• W2074838036 hasConcept C2522874641 @default.
• W2074838036 hasConcept C2777841672 @default.
• W2074838036 hasConcept C2779600528 @default.
• W2074838036 hasConcept C2779690655 @default.
• W2074838036 hasConcept C2779692357 @default.
• W2074838036 hasConcept C2779904517 @default.
• W2074838036 hasConcept C2780727368 @default.
• W2074838036 hasConcept C2780980013 @default.
• W2074838036 hasConcept C71924100 @default.
• W2074838036 hasConceptScore W2074838036C126322002 @default.
• W2074838036 hasConceptScore W2074838036C12914427 @default.
• W2074838036 hasConceptScore W2074838036C159047783 @default.
• W2074838036 hasConceptScore W2074838036C203014093 @default.
• W2074838036 hasConceptScore W2074838036C22070199 @default.
• W2074838036 hasConceptScore W2074838036C2522874641 @default.
• W2074838036 hasConceptScore W2074838036C2777841672 @default.
• W2074838036 hasConceptScore W2074838036C2779600528 @default.
• W2074838036 hasConceptScore W2074838036C2779690655 @default.
• W2074838036 hasConceptScore W2074838036C2779692357 @default.
• W2074838036 hasConceptScore W2074838036C2779904517 @default.
• W2074838036 hasConceptScore W2074838036C2780727368 @default.
• W2074838036 hasConceptScore W2074838036C2780980013 @default.
• W2074838036 hasConceptScore W2074838036C71924100 @default.
• W2074838036 hasLocation W20748380361 @default.
• W2074838036 hasOpenAccess W2074838036 @default.
• W2074838036 hasPrimaryLocation W20748380361 @default.
• W2074838036 hasRelatedWork W1978438389 @default.
• W2074838036 hasRelatedWork W2018522116 @default.
• W2074838036 hasRelatedWork W2032086068 @default.
• W2074838036 hasRelatedWork W2052726310 @default.
• W2074838036 hasRelatedWork W2074838036 @default.
• W2074838036 hasRelatedWork W2098772131 @default.
• W2074838036 hasRelatedWork W2331987696 @default.
• W2074838036 hasRelatedWork W2424308236 @default.
• W2074838036 hasRelatedWork W3036822398 @default.
• W2074838036 hasRelatedWork W4312066813 @default.
• W2074838036 hasVolume "3" @default.
• W2074838036 isParatext "false" @default.
• W2074838036 isRetracted "false" @default.

• next